Ironwood Pharmaceuticals Stock Forecast - Naive Prediction

IRWD Stock  USD 7.60  0.05  0.65%   
The Naive Prediction forecasted value of Ironwood Pharmaceuticals on the next trading day is expected to be 5.97 with a mean absolute deviation of  0.70  and the sum of the absolute errors of 42.84. Ironwood Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Ironwood Pharmaceuticals stock prices and determine the direction of Ironwood Pharmaceuticals's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Ironwood Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns. Although Ironwood Pharmaceuticals' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Ironwood Pharmaceuticals' systematic risk associated with finding meaningful patterns of Ironwood Pharmaceuticals fundamentals over time.
Check out Historical Fundamental Analysis of Ironwood Pharmaceuticals to cross-verify your projections.
For information on how to trade Ironwood Stock refer to our How to Trade Ironwood Stock guide.
  
At present, Ironwood Pharmaceuticals' Asset Turnover is projected to increase slightly based on the last few years of reporting. . The current year's Net Income Applicable To Common Shares is expected to grow to about 211.4 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 137.1 M.

Open Interest Against 2024-04-19 Ironwood Option Contracts

Although open interest is a measure utilized in the options markets, it could be used to forecast Ironwood Pharmaceuticals' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Ironwood Pharmaceuticals' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Ironwood Pharmaceuticals stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Ironwood Pharmaceuticals' open interest, investors have to compare it to Ironwood Pharmaceuticals' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Ironwood Pharmaceuticals is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Ironwood. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Most investors in Ironwood Pharmaceuticals cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Ironwood Pharmaceuticals' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Ironwood Pharmaceuticals' price structures and extracts relationships that further increase the generated results' accuracy.
A naive forecasting model for Ironwood Pharmaceuticals is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of Ironwood Pharmaceuticals value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

Ironwood Pharmaceuticals Naive Prediction Price Forecast For the 20th of April

Given 90 days horizon, the Naive Prediction forecasted value of Ironwood Pharmaceuticals on the next trading day is expected to be 5.97 with a mean absolute deviation of 0.70, mean absolute percentage error of 0.95, and the sum of the absolute errors of 42.84.
Please note that although there have been many attempts to predict Ironwood Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Ironwood Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Ironwood Pharmaceuticals Stock Forecast Pattern

Backtest Ironwood PharmaceuticalsIronwood Pharmaceuticals Price PredictionBuy or Sell Advice 

Ironwood Pharmaceuticals Forecasted Value

In the context of forecasting Ironwood Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Ironwood Pharmaceuticals' downside and upside margins for the forecasting period are 0.70 and 11.24, respectively. We have considered Ironwood Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
7.60
5.97
Expected Value
11.24
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Ironwood Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Ironwood Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria118.0606
BiasArithmetic mean of the errors None
MADMean absolute deviation0.7023
MAPEMean absolute percentage error0.0675
SAESum of the absolute errors42.8421
This model is not at all useful as a medium-long range forecasting tool of Ironwood Pharmaceuticals. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict Ironwood Pharmaceuticals. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for Ironwood Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Ironwood Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Ironwood Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
2.547.8113.08
Details
Intrinsic
Valuation
LowRealHigh
4.489.7515.02
Details
6 Analysts
Consensus
LowTargetHigh
15.0216.5018.32
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.100.200.48
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Ironwood Pharmaceuticals. Your research has to be compared to or analyzed against Ironwood Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Ironwood Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Ironwood Pharmaceuticals.

Other Forecasting Options for Ironwood Pharmaceuticals

For every potential investor in Ironwood, whether a beginner or expert, Ironwood Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Ironwood Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Ironwood. Basic forecasting techniques help filter out the noise by identifying Ironwood Pharmaceuticals' price trends.

Ironwood Pharmaceuticals Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ironwood Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Ironwood Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Ironwood Pharmaceuticals by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Ironwood Pharmaceuticals Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Ironwood Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Ironwood Pharmaceuticals' current price.

Ironwood Pharmaceuticals Market Strength Events

Market strength indicators help investors to evaluate how Ironwood Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Ironwood Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Ironwood Pharmaceuticals stock market strength indicators, traders can identify Ironwood Pharmaceuticals entry and exit signals to maximize returns.

Ironwood Pharmaceuticals Risk Indicators

The analysis of Ironwood Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Ironwood Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting ironwood stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Ironwood Pharmaceuticals Investors Sentiment

The influence of Ironwood Pharmaceuticals' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Ironwood. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Ironwood Pharmaceuticals' public news can be used to forecast risks associated with an investment in Ironwood. The trend in average sentiment can be used to explain how an investor holding Ironwood can time the market purely based on public headlines and social activities around Ironwood Pharmaceuticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Ironwood Pharmaceuticals' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Ironwood Pharmaceuticals' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Ironwood Pharmaceuticals' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Ironwood Pharmaceuticals.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Ironwood Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Ironwood Pharmaceuticals' short interest history, or implied volatility extrapolated from Ironwood Pharmaceuticals options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Ironwood Pharmaceuticals is a strong investment it is important to analyze Ironwood Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ironwood Pharmaceuticals' future performance. For an informed investment choice regarding Ironwood Stock, refer to the following important reports:
Check out Historical Fundamental Analysis of Ironwood Pharmaceuticals to cross-verify your projections.
For information on how to trade Ironwood Stock refer to our How to Trade Ironwood Stock guide.
You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Ironwood Stock analysis

When running Ironwood Pharmaceuticals' price analysis, check to measure Ironwood Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ironwood Pharmaceuticals is operating at the current time. Most of Ironwood Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Ironwood Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ironwood Pharmaceuticals' price. Additionally, you may evaluate how the addition of Ironwood Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Is Ironwood Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ironwood Pharmaceuticals. If investors know Ironwood will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ironwood Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.69)
Earnings Share
(6.45)
Revenue Per Share
2.848
Quarterly Revenue Growth
0.097
Return On Assets
0.1339
The market value of Ironwood Pharmaceuticals is measured differently than its book value, which is the value of Ironwood that is recorded on the company's balance sheet. Investors also form their own opinion of Ironwood Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Ironwood Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ironwood Pharmaceuticals' market value can be influenced by many factors that don't directly affect Ironwood Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ironwood Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ironwood Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ironwood Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.